Patients with a recent first episode of schizophrenia who are treated with a long-acting injectable ...
New findings from a phase 3 clinical trial, published today in AJP in Advance, suggest that a recent...
A three-month formulation of paliperidone palmitate administered four times yearly as a long-acting ...
The duration of psychiatric illness and treatment for patients after first-episode schizophrenia spe...
Yesterday the Food and Drug Administration (FDA) released a warning stating that the use of ziprasid...
Treatment with clozapine alone instead of antipsychotic polypharmacy for treatment-resistant schizop...
Predicting violence among psychiatric patients “remains an inexact science,” a bit like predicting t...
Schizophrenia appears to be “heterogenous”—that is, comprising a group of related disorders each of ...
People with serious mental illnesses such as schizophrenia or bipolar disorder are at greater risk f...
